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The effectiveness of p-aminobenzoic acid
(PABA) in overcoming sulfanilamide (SA)
growth inhibition of Escherichia coli was
explained on the basis that PABA was an
essential metabolite and that SA interfered with
-its utilization by the cell (Woods, 1940). Reversal
of sulfonamide action by structurally unrelated
metabolites such as methionine, xanthine, serine,
thymine and valine (Shive, 1950; Winkler and
de Haan, 1948; Winkler et al., 1949) was assumed
to be due to their being products of PABA asso-
ciated enzyme system(s). The activity of these
metabolites in replacing the need for PABA in
the nutrition of induced mutants of E. coli
(Lampen et at., 1946, 1949) lent support to this
interpretation.
Pteroylglutamic acid (PGA) is known to over-
come sulfonamide inhibition non-competitively
and to replace the PABA requirement of certain
organisms (Lampen and Jones, 1946, 1947). PGA
is, however, inactive with E. coli, though the
organism is known to elaborate a factor with
folic acid (FA) activity, this synthesis being in-
hibited by sulfonamides (Lascelles and Woods,
1952).
Vitamin B12 has been reported (Shive, 1950) to
potentiate PABA action as, in its presence, higher
concentrations of SA are required to inhibit the
biosynthesis of methionine, xanthine and serine.
Also vitamin B12 is known to decrease the PABA
requirement for a PABA auxotroph of E. coli
(Davis, 1951; Gots and Chu, 1952). In combina-
tion with methionine, it further decreases the
need for PABA (Gots and Chu, 1952).
The foregoing and other known relationships
among PABA, FA and vitamin B12 suggested a
study of their effects in the reversal of sulfona-
mide action by the antagonists reported by Shive
(1950) and Winkler and de Hann (1948). Such a
study was also indicated by our observation that,
with sulfadiazine (SD) as inhibitor and at rather
high concentrations of the drug, the non-com-
petitive antagonists reported by Winkler et al.
(1950) in E. coli were no longer sufficient to re-
verse growth inhibition. A preliminary report
has appeared (Alimchandani and Sreenivasan,
1955a).
METHODS
E. coli Macleod strain was maintained by
fortnightly transfer on peptone yeast extract
agar slants. The organism was grown at 30 C for
24 hr.
The basal medium employed was that of Green
and Sevag (1946). The glucose was freed from
traces of PABA by adsorption on norite at pH
3.0. The pH of the medium was adjusted to 7.6.
A 100 mg per cent solution of SD was prepared
in the double strength medium, and the pH
was readjusted to 7.6. In the growth experi-
ments, concentrations of SD were varied by
using appropriate amounts of this SD solution
in a final volume of 5 ml of the double
strength medium which, after other additions, if
any, was made to 10 ml with distilled water. All
other solutions were adjusted to pH 7.6. With
optically active amino acids, the racemic forms
were employed. The media in tubes were steri-
lized at 15 lb of steam pressure for 15 min. A
40-fold dilution of a 24-hr growth in the basal
medium was used to inoculate the tubes dropwise.
Growth was measured turbidimetrically on a
Klett-Summerson photoelectric colorimeter at
660 m,u and expressed in terms of galvanometer
deflections. All results reported are averages of at
least three different sets of experiments.
RESULTS
In studies on the reversal of growth inhibition
of E. coli by SD it was observed that, as the drug
concentration was increased, sequential additions
of methionine, xanthine, serine, thymine, and
valine were necessary to bring about reversal. The
observations were in conformity with those re-
ported by Winkler and de Haan (1948) for SA
and, at a concentration of 2 to 5 mg per cent,
538
INHIBITION OF E. COLI BACTERIOSTASIS
almost complete reversal of inhibition was ob-
servable with all 5 metabolites. At a concentra-
tion of 30 mg per cent there was partial reversal.
However, as the concentration of the drug was
further increased to 50 mg per cent they were no
longer effective even when added in larger con-
centrations (table 1). In fact, it was observed
that increased concentrations of serine were
inhibitory.
Effect of mixtures of amino acids, purines and
pyrimidines and vitamins. The inability of these
metabolites to overcome growth inhibition by
SD suggested that the drug blocked biosynthesis
of one or more other essential metabolites. In an
attempt to ascertain its (their) nature, mixtures
of purines and pyrimidines, amino acids and the
B group of vitamins were tried (table 2) and it was
found that the amino acid mixture and, to a lesser
extent, the Nitamins would reverse drug inhibi-
tion of growth considerably. Incidentally, the
amino acid mixture was stimulatory to growth
even in the absence of added SD.
Using individual amino acids, it was observed
that only glycine and, to a lesser extent, threonine
were active in partially reversing SD growth
inhibition. When added on a molar basis, glycine
was found to be more active than threonine
TABLE 1
Reversal of SD growth inhibition of Escherichia coli
by methionine xanthine, serine, thymine and
valine
Additions to 10 MI of Basal Medium
1 2 3 4 5 6
SD per DL- As in As in As in As in
10 ml of Methio- (2) + (3) + (4)y+ (5) +
Medium nine, xanthine, serine, thy- valine,
0.5 mg. 0.25 mg. 0.2 mg 0n25mg 0.5 mg
Growth at 48 hr (in terms of Klett readings)
0 47 48 46 48 47 50
25 0 * 30 48 47 50 49
50 0 6 41 49 50 49
100 1 0 23 47 48 48
200 0 0 7 39 50 47
500 0 1 1 11 44 42
mg
1 0 0 1 1 21 41
2 0 0 0 1 7 27
3 0 0 0 0 1 16
4 0 0 0 0 0 2
5 0 0 0 0 0 0
TABLE 2
Effect of amino acids, purines and pyrimidines and
vitamins on SD growth inhibition of Escherichia
coli
Growth at 48 Hr
Additions to 10 ml of Medium* With SD, Without
5 mg per SDtou
10 ml S
None........................ 0 51
Amino acid mixturet........... 54 75
Vitamin mixturet.............. 26 49
Purine-pyrimidine mixture§.... 0 50
PABA, 0.5 mg................. 49 48
* Basal medium + methionine (0.5 mg) +
xanthine (0.25 mg) + serine (0.2 mg) + thymine
(0.25 mg) + valine (0.5 mg).
t 0.2 mg each of alanine, arginine, asparagine,
aspartic acid, cysteine, glutamic acid, glycine,
histidine, hydroxyproline, isoleucine, leucine,
lysine, norleucine, norvaline, phenylalanine,
proline, threonine, tryptophan and tyrosine.
$ Thiamin HCl, riboflavin, nicotinic acid,
pantothenic acid and pyridoxin HCl (10,ug each),
pteroylglutamic acid (3 ug), leucovorin [Lederle]
(6,g), biotin and vitamin B12 (10 mug each).
§ 0.1 mg each of adenine, guanine and uracil.
TABLE 3
Comparative effects of glycine and threonine
Growth at 48 Hr
Addition to Medium* With SD, Without
5 mg per SDtou
10 ml S
None ........... ............... 0 52
Glycine (M/6000)............... 23 51
Glycine (M/3000)............... 28 52
Glycine (M/1500) ............... 27 52
DL-Threonine (M/6000) ......... 15 49
DL-Threonine (M/3000)......... 19 51
DL-Threonine (M/1500) ......... 19 49
Glycine + DL-Threonine
(M/6000 each) ................ 26 50
Glycine + DL-Threonine
(M/3000 each) ................ 29 49
Glycine + DL-Threonine
(M/1500 each)................ 29 51
* As in table 2.
(table 3). A combination of these two did not
improve the effect of glycine alone, suggesting
that glycine was the product of the blocked en-
zyme reaction. The existence of an enzyme system
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TABLE 4
Effect of glycine and vitamin B12
Growth at 48 Hr
Addition to 10 ml of Medium* With SD, Without
5 mg per SDtou
10 ml S
None ........................ 0 50
Glycine (0.25 mg).............. 27 49
Vitamin B12 (10 m/Ag) .......... 21 49
Glycine (0.25 mg) + vitamin
B12 (10 mpg)................. 41 51
PABA (0.5 mg) ................ 50 52
* As in table 2.
TABLE 5
Effect of purine mixture
Growth at 48 Hr
Additions to 10 ml of Medium* With SD, |ithout
5 mg per SDtou
10 ml S
None ........................ 0 46
PABA (0.5 mg) ................ 46 47
Xanthine (0.25 mg) ............ 40 48
Xanthine (0.5 mg) ............. 38 47
Adenine + guanine + xanthine
(0.1 mg each) ................ 45 49
* Basal medium + methionine (0.5 mg) +
serine (0.2 mg) + thymine (0.25 mg) + valine
(0.5 mg) + glycine (0.25 mg) + vitamin B12
(10 mpAg).
converting threonine to glycine in the organism
is reported later.
The activity of the B vitamins in partially
overcoming the growth inhibition was followed
by using them individually under the same ex-
perimental condition as for the amino acids.
Only vitamin B12 was observed to have an
ability partially to reverse SD inhibition. Gly-
cine and vitamin B12, in combination, showed
reversal effects which nearly approached that
obtained with PABA (table 4).
In these experiments, the substitution of
xanthine by a mixture of purines gave reversal
of growth inhibition comparable to that obtained
with PABA (table 5).
Glycine-serine relationship. The requirement
for glycine in the presence of serine by the organ-
ism was rather unexpected in view of the known
interchangeability of the two amino acids in
several systems (Roepke et al., 1944; Tatum,
1949). Whether this effect of glycine was due to
an insufficient amount of serine in the medium
was ascertained by using increased concentration
of the latter. However, serine at concentrations
higher than 0.2 mg per ml was found to be toxic.
Increased concentrations of glycine could not
also substitute for serine (table 6). It would
seem therefore that in this organism there does
not exist the mechanism for serine to glycine
conversion. Alternatively, this step may be
blocked by SD.
Enzymic conversion of threonine to glycine in
E. coli. The activity of threonine in replacing
glycine observed in the above experiments (table
3) suggested the existence of an enzymic mecha-
nism in the organism capable of bringing about the
transformation of threonine to glycine and acetal-
dehyde similar to the one reported in liver and in
yeast (16, 17). This was ascertained by the
following experiment.
Cells of E. coli grown in 500-ml lots of basal
medium in Roux bottles were harvested by
centrifugation and washed twice with ice water.
The cells were crushed thoroughly with sand and
freed from the latter by decantation. Aliquots
of the crushed cell suspension (approximately 3
mg dry wt) were incubated with threonine in
phosphate buffer at pH 7.2 (final conc. of buffer
adjusted to 0.1 M). After incubation at 30 C
TABLE 6
Non-interchangeability of serine and glycine
Growth at 48 Hr
Addition to 10 ml of Mediums With SD, Without
5mg per SDtou
10 ml S
None ......................... 0 49
Serine (0.1 mg)................ 19 50
Serine (0.15 mg)............... 24 48
Serine (0.2 mg)................ 24 49
Serine (0.3 mg)................ , 22 47
Serine (0.4 mg)................ 15 44
Glycine (0.25 mg).............. 0 48
Glycine (0.5 mg)............... 0 47
Serine (0.2 mg) + glycine (0.25
mg) ........................ 47 49
* Basal medium + methionine (0.5 mg) +
thymine (0.25 mg) + adenine, guanine and
xanthin (0.1 mg each) + valine (0.5 mg) +
vitamin B12 (10 mIug).
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TABLE 7
Conversion of threonine to glycine in Escherichia
coli
Glycine Formed
in 2 Hr
System
Wto WithWithout threoninethreonine 0.6 mmole
sg/lO mg dry wi cells
Crushed cells.................. 150 195
Crushed cells, heated.......... 135 132
for 2 hr the reaction was stopped by addition
of sodium tungstate and sulfuric acid, and gly-
cine formed was estimated by the method of
Alexander et al. (1945). It was observed (table 7)
that threonine gives rise to glycine under the
conditions of these experiments. In one experi-
ment, when hydroxylamine (1 mmole final
concentration) was included to trap the acetal-
dehyde, there was a 20 per cent increase in
glycine formed.
Inactivity of PGA and leucovorin. The relation-
ship disclosed earlier between PABA, FA and
vitamin B12 suggested testing of their reversal
effect on SD growth inhibition.
Employing the basal medium with additions
of methionine, serine, thymine, valine, glycine,
vitamin B12 and purine mixture (as in table 5)
it was observed that none of these metabolites
could be replaced by PGA (3 ,ug) or leucovorin
(LV) (6 ,g). This was so even when the concen-
tration of B12 was increased to 100 m,ug which was
above that for reversal of SD inhibition.
Use of methionine precursors. The ability of
methionine but not homocysteine or homocystine
to replace vitamin B12 for growth of B12 auxo-
trophs of E. coli implicated vitamin B12 in E.
coli metabolism in the conversion of homo-
cysteine to methionine (Davis and Mingioli,
1950). However, when with E. coli methionine
in the composite medium with purine mixture
(table 5) was replaced by homocystine or homo-
cysteine (0.5 mg each) no reversal of SD growth
inhibition occurred. Increasing vitamin B12
concentration to 100 m,ug also had no effect.
This would suggest that, if homocystine or
homocysteine were to be the precursors of methi-
onine in E. coli, vitamin B12 and the other
additions present in the medium are not suffi-
cient for the biosynthesis of the methyl moiety.
DISCUSSION
The present experiments have shown that, in
addition to the other metabolites discovered by
Shive (1950) and Winkler and de Haan (1948),
the biosynthesis of glycine is yet another reaction
mediated by PABA and blocked by SD. The
activity, to a lesser extent, of threonine at the
stage where glycine is involved in overcoming
SD inhibition, and the absence of any increase
in antisulfonamide activity when these two
amino acids are used in combination, suggests
that it is the synthesis of glycine that is blocked.
The activity of threonine thus appears to be due
to an ability of the organism to convert it to
glycine. The existence of such a mechanism in
E. coli cells was confirmed experimentally. Such
a possibility has been indicated by Ravel et al.
(1948) who showed that accumulation of 4-
amino-5-imidazole carboxamide was increased
by glycine and to a lesser extent by threonine
during sulfonamide bacteriostasis. Other workers
also have shown the presence of an enzyme, in
tissues of various animals and in plasmolysed
yeast cells, capable of converting threonine to
glycine (Braunshtein and Vilenkina, 1949;
Meltzer and Sprinson, 1952).
The interchangeability of glycine and serine in
several systems (Roepke et al., 1944; Tatum,
1949) suggested that the need for glycine could
be due to an insufficiency of serine and tvice
versa. However, using increased concentrations
of both these metabolites, it has been demon-
strated that they cannot replace each other as
antisulfonamide agents, which suggests that the
biosynthesis of both these metabolites is blocked
independently by the drug.
The potentiating action of vitamin B12 on the
reversal of SD growth inhibition by the various
metabolites, and its sparing effect on PABA
requirement of E. coli mutants (Davis, 1951),
could be explained as due to a function for
PABA in B12 synthesis or for B12 in the biosyn-
thesis of PABA or of its conversion to its active
coenzyme form. Davis (1951) had suggested that
probably PABA is the precursor of the benzi-
midazole moiety of B12. However, pseudovitainin
B12, which contains adenine in place of the
benzimidazole moiety, possesses the activity of
the vitamin for microorganisms (Davis, 1952).
In the case of the B12 auxotroph of E. coli,
methionine replaces the vitamin for growth
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(Davis and Mingioli, 1950). But during sul-
fanilamide bacteriostasis higher concentrations
of the drug are required to inhibit growth in the
presence of B12 than in the presence of methionine
(Alimchandani and Sreenivasan, 1955b). This
suggests that B12 has other functions than the
biosynthesis of methionine in the E. coli mutant,
and that these additional functions become
evident or are assumed during sulfonamide
growth inhibition. This latent role(s) of vitamin
B12 appears to be identical to that exhibited by
the vitamin with the wild strain during inhibition
of growth by sulfanilamide (Shive, 1950).
Growth studies with B12 auxotroph have
implicated B12 in the synthesis of methionine
from homocysteine (Davis and Mingioli, 1950).
The inability, however, of homocysteine and
B12 to replace methionine in overcoming SD
bacteriostasis in the wild strain suggests that
PABA also is involved in methionine synthesis of
this stage. Gibson and Woods (1952) have indi-
cated the role of these two vitamins in this con-
version. Cell-suspensions of an E. coli mutant
requiring PABA have been shown by these
workers to require PABA for this transformation;
the further addition of B12 is stimulatory though
B12 alone is inactive.
The greater activity of the purine mixture
over xanthine alone suggests either that xanthine
is not a normal intermediate in the biosynthesis
of other purines or that SD interferes with the
interconversion of purines as well.
The inability of PGA or LV to replace PABA
for the growth of a PABA auxotroph has also
been reported by Davis (1951). It has further
been observed by us that both PGA and LV,
even in the presence of large concentrations of
B12, could not substitute for any of the other
metabolites in overcoming SD inhibition. This
could be due to any of the following reasons:
(1) PABA is involved in these syntheses not
through FA. (2) PGA or LV are not intermedi-
ates in the biosynthetic pathway of E. coli for
the formation of the functionally active form of
FA required by the organism. (3) Preformed
PGA and LV cannot be absorbed by this organ-
ism. These points are further discussed in a
subsequent communication.
Contrary to the observations of Winkler and
de Haan (1948) and Shive (1950), PGA or LV
could not substitute for thymine in the combina-
tion of metabolites effective in reversing sul-
fonamide growth inhibition in E. coli. In our
experience even LV was ineffective. A similar
inactivity of PGA is reported by Davis (1951)
with an E. coli PABA auxotroph.
SUMMARY
Reversal of sulfadiazine (SD) growth inhibition
in Escherichia coli Macleod strain has been ex-
amined with several metabolites functionally
related to p-aminobenzoic acid (PABA).
It was observed that vitamin B12 and glycine
or to a lesser extent threonine were essential
(in addition to the known combination of
methionine, xanthine, serine, thymine and valine)
to obtain reversal at high concentrations of SD.
Substitution of xanthine by a mixture of
purines together with additions of the above
mentioned metabolites gave reversal of growth
inhibition comparable to that obtained with
PABA.
The activity of threonine was shown to be due
to an ability of the organism to convert it to
glycine.
From studies with varying concentrations of
glycine and serine, in SD inhibited organisms,
it was concluded that sulfonamide blocks the
biosynthetic mechanism(s) for glycine serine
interconversion.
Folic acid or leucovorin were inactive in
reversing SD growth inhibition or in replacing
any of the SD reversing metabolites even in the
presence of excess B12.
Homocysteine or homocystine could not
replace methionine even in combination with
B12.
The observations are discussed in relation to
the inhibition steps in sulfonamide bacteriostasis.
REFERENCES
ALEXANDER, B., LANDWEHR, G., AND SELIGMAN,
A. M. 1945 A specific micromethod for the
colorimetric determination of glycine in blood
and urine. J. Biol. Chem., 160, 51-59.
ALIMCHANDANI, H. R. AND SREENIVASAN, A.
1955a Inhibition steps in sulfonamide bac-
teriostasis. Nature, 176, 702.
ALIMCHANDANI, H. R. AND SREENIVASAN, A.
1955b Reversal of sulfonamide action in
Escherichia coli (B12 auxotroph) by vitamin
B12. Biochim. et Biophys. Acta, 18, 567.
BRAUNSHTEIN, A. E. AND VILENKINA, G. Ya.
1949 Enzymic formation of glycine from
serine, threonine, and other hydroxyamino
acids in animal tissue. Chem. Abstr., 43,
7986.
542 [VOL. 73
INHIBITION OF E. COLI BACTERIOSTASIS
DAVIS, B. D., AND MINGIOLI, E. S. 1950 Mu-
tants of Escherichia coli requiring methionine
or vitamin B12. J. Bacteriol., 60, 17-28.
DAVIS, B. D. 1951 Aromatic biosynthesis. III.
Role of p-aminobenzoic acid in the formation
of vitamin B12. J. Bacteriol., 62, 221-230.
DAVIS, B. D. 1952 Utilization of pseudovitamin
B12 by mutants of Escherichia coli. J. Bac-
teriol., 64, 432-433.
GIBSON, F. AND WOODS, D. D. 1952 The syn-
thesis of methionine from homocysteine by
Escherichia coli. Biochem. J. (London), 51, v.
GOTS, J. S. AND CHU, E. C. 1952 Studies on
purine metabolism in bacteria. I. The role
of p-aminobenzoic acid. J. Bacteriol., 64,
537-546.
GREEN, M. N. AND SEVAG, M. G. 1946. Failure
to demonstrate transmethylation of homo-
cystine by a strain of Escherichia coli requir-
ing methionine for growth. Arch. Biochem.,
9, 129-132.
LAMPEN, J. 0. AND JONES, M. J. 1946 The an-
tagonism of sulfonamide inhibition of certain
lactobacilli and enterococci by pteroylglu-
tamic acid and related compounds. J. Biol.
Chem., 166, 435-448.
LAMPEN, J. 0. AND JONES, M. J. 1947 The
growth-promoting and antisulfonamide ac-
tivity of p-aminobenzoic acid, pteroylglu-
tamic acid, and related compounds for Lacto-
bacillus arabinosus and Streptobacterium
plantarum. J. Biol. Chem., 170, 133-146.
LAMPEN, J. O., JONES, M. J., AND ROEPKE, R. R.
1949 Mutant strains of Escherichia coli
unable to synthesize p-aminobenzoic acid.
J. Biol. Chem., 180, 423-434.
LAMPEN, J. O., ROEPKE, R. R., AND JONES, M. J.
1946 The replacement of p-aminobenzoic
acid in the growth of a mutant strain of Es-
cherichia coli. J. Biol. Chem., 164, 789-790.
LASCELLES, J. AND WOODS, D. D. 1952 The syn-
thesis of folic acid by Bacterium coli and
Staphylococcus aureus and its inhibition by
sulfonamides. Brit. J. Exptl. Pathol., 33,
288-303.
MELTZER, H. L. AND SPRINSON, D. B. 1952 The
synthesis of 4-C'4, N15-L-threonine and a study
of its metabolism. J. Biol. Chem., 197, 461-
474.
RAVEL, J. M., EAKIN, R. E., AND SHIVE, W. 1948
Glycine, a precursor of 5(4)-amino-4(5)-
imidazolecarboxamide. J. Biol. Chem., 172,
67-70.
ROEPKE, R. R., LIBBY, R. L., AND SMALL, M. H.
1944 Mutation or variation of Escherichia
coli with respect to growth requirements.
J. Bacteriol., 48, 401-412.
SHIVE, W. 1950 The utilization of antimetabo-
lites in the study of biochemical processes in
living organisms. Ann. N. Y. Acad. Sci.,
52, 1212-1234.
TATUM, E. L. 1949 Amino acid metabolism in
mutant strains of microorganisms. Federa-
tion Proc., 8, 511-517.
WINKLER, K. C. AND DE HAAN, P. G. 1948 Ac-
tion of sulfanilamide. XII. A set of non-com-
petitive sulfanilamide antagonists for Escheri-
chia coli. Arch. Biochem., 18, 97-107.
WINKLER, K. C., DE HAAN, P. G., AND VAN DE
LANGERIJT, J. 1949 Action of sulfanilam-
ide. XII. Non-competitive sulfonamide an-
tagonists for Escherichia coli. Antonie van
Leeuwenhoek J. Microbiol. Serol., 15, 129-135.
WOODS, D. D. 1940 The relation of p-amino-
benzoic acid to the mechanism of the action
of sulfanilamide. Brit. J. Exptl. Pathol., 21,
74-90.
19571 543
